In vitro characterization of chemokine-loaded liposomes

References

• American Cancer Society. (2019). Cancer facts & figures 2019. Atlanta: Author.
   Google Scholar
• Androulla, M. N., & Lefkothea, P. C. (2018). CAR T-cell therapy: A new Era in cancer immunotherapy. Current Pharmaceutical Biotechnology, 19(1), 5–9. doi:10.2174/1389201019666180418095526
   PubMed Web of Science ®Google Scholar
• Ansel, K. M., Harris, R. B., & Cyster, J. G. (2002). CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity, 16(1), 67–76.
   PubMed Web of Science ®Google Scholar
• Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., … Bruneval, P. (2013). Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity, 39(4), 782–795. doi:10.1016/j.immuni.2013.10.003
   PubMed Web of Science ®Google Scholar
• Brändlein, S., Pohle, T., Ruoff, N., Wozniak, E., Müller-Hermelink, H. K., & Vollmers, H. P. (2003). Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans. Cancer Research, 63(22), 7995–8005.
   PubMed Web of Science ®Google Scholar
• D’Aloia, M. M., Zizzari, I. G., Sacchetti, B., Pierelli, L., & Alimandi, M. (2018). CAR-T cells: The long and winding road to solid tumors. Cell Death & Disease, 9(3), 282. doi:10.1038/s41419-018-0278-6
   PubMed Web of Science ®Google Scholar
• Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011). Nanoparticle PEGylation for imaging and therapy. Nanomedicine, 6(4), 715–728. doi:10.2217/nnm.11.19
   PubMed Web of Science ®Google Scholar
• Kar, U. K., Srivastava, M. K., Andersson, Å., Baratelli, F., Huang, M., Kickhoefer, V. A., … Sharma, S. (2011). Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth. PloS One, 6(5), e18758. doi:10.1371/journal.pone.0018758
   PubMed Web of Science ®Google Scholar
• Ko, Y. T., & Bickel, U. (2012). Liposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique. AAPS PharmSciTech, 13(2), 373–378. doi:10.1208/s12249-012-9757-8
   PubMed Web of Science ®Google Scholar
• Lei, X., Liu, C., Azadzoi, K., Li, C., Lu, F., Xiang, A., … Yang, J. (2015). A novel IgM–H-Ficolin complement pathway to attack allogenic cancer cells in vitro. Scientific Reports, 5, 7824.
   PubMed Web of Science ®Google Scholar
• Li, G., Tian, L., Hou, J. M., Ding, Z. Y., He, Q. M., Feng, P., … Peng, F. (2005). Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 11(11), 4217–4224. doi:10.1158/1078-0432.CCR-04-2117
   PubMed Web of Science ®Google Scholar
• Mohit, E., & Rafati, S. (2012). Chemokine-based immunotherapy: Delivery systems and combination therapies. Immunotherapy, 4(8), 807–840. doi:10.2217/imt.12.72
   PubMed Web of Science ®Google Scholar
• Moratz, C., & Kehrl, J. H. (2004). vitro and in vivo assays of B-lymphocyte migration. In B Cell Protocols (pp. 161–171). Humana Press.
   Google Scholar
• Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000). A new temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Research, 60(5), 1197–1201.
   PubMed Web of Science ®Google Scholar
• Needham, D., & Dewhirst, M. W. (2001). The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Advanced Drug Delivery Reviews, 53(3), 285–305.
   PubMed Web of Science ®Google Scholar
• Pockaj, B. A., Sherry, R. M., Wei, J. P., Yannelli, J. R., Carter, C. S., Leitman, S. F., … Yang, J. C. (1994). Localization of 111Indium‐labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response. Cancer, 73(6), 1731–1737. doi:10.1002/1097-0142(19940315)73:6<1731::aid-cncr2820730630>3.0.co;2-h
   PubMed Web of Science ®Google Scholar
• Popi, A. F., Longo-Maugéri, I. M., & Mariano, M. (2016). An overview of B-1 cells as antigen-presenting cells. Frontiers in Immunology, 7, 138.
   PubMed Web of Science ®Google Scholar
• Ray, A., & Dittel, B. N. (2010). Isolation of mouse peritoneal cavity cells. Journal of Visualized Experiments: JoVE, (35). doi:10.3791/1488
   Google Scholar
• Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012). Adoptive immunotherapy for cancer: Harnessing the T cell response. Nature Reviews Immunology, 12(4), 269. doi:10.1038/nri3191
   PubMed Web of Science ®Google Scholar
• Slaney, C. Y., Kershaw, M. H., & Darcy, P. K. (2014). Trafficking of T cells into tumors. Cancer Research, 74(24), 7168–7174. doi:10.1158/0008-5472.CAN-14-2458
   PubMed Web of Science ®Google Scholar
• Steichen, S. D., Caldorera-Moore, M., & Peppas, N. A. (2013). A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 48(3), 416–427. doi:10.1016/j.ejps.2012.12.006
   PubMed Web of Science ®Google Scholar
• Tsiantoulas, D., Diehl, C. J., Witztum, J. L., & Binder, C. J. (2014). B cells and humoral immunity in atherosclerosis. Circulation Research, 114(11), 1743–1756. doi:10.1161/CIRCRESAHA.113.301145
   PubMed Web of Science ®Google Scholar
• Vollmers, H. P., & Brandlein, S. (2005). Death by stress: Natural IgM-induced apoptosis. Methods and Findings in Experimental and Clinical Pharmacology, 27(3), 185–192. doi:10.1358/mf.2005.27.3.890876
   PubMedGoogle Scholar